Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Letter to the Editor

Future Opportunities in Malaria Management Offered by Probiotics

Author(s): Amandeep Singh* and Rohit Bhatia

Volume 24, Issue 5, 2024

Published on: 15 January, 2024

Article ID: e150124225633 Pages: 3

DOI: 10.2174/0118715265271259231118154255

Price: $65

conference banner
Graphical Abstract

[1]
Deng SQ, Cai Y, Wang DQ. Editorial: Novel strategies for controlling mosquito-borne diseases. Front Public Health 2023; 11: 1171634.
[http://dx.doi.org/10.3389/fpubh.2023.1171634] [PMID: 36992881]
[2]
Kogan F, Kogan F. Malaria Burden. Springer 2020.
[http://dx.doi.org/10.1007/978-3-030-46020-4_2]
[3]
Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med 2021; 385(13): 1163-71.
[http://dx.doi.org/10.1056/NEJMoa2101746] [PMID: 34551228]
[4]
Al-Awadhi M, Ahmad S, Iqbal J. Current status and the epidemiology of malaria in the Middle East Region and beyond. Microorganisms 2021; 9(2): 338.
[http://dx.doi.org/10.3390/microorganisms9020338] [PMID: 33572053]
[5]
Tachibana M, Takashima E, Morita M, et al. Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation. Parasitol Int 2022; 87: 102525.
[http://dx.doi.org/10.1016/j.parint.2021.102525] [PMID: 34896614]
[6]
Etefia E, Etoh PI. Malaria vaccine development: Challenges and prospects. Med Pharmac J 2023; 2(1): 28-42.
[http://dx.doi.org/10.55940/medphar202225]
[7]
Khan N, Awasthi G, Das A. How can the complex epidemiology of malaria in India impact its elimination? Trends Parasitol 2023; 39(6): 432-44.
[http://dx.doi.org/10.1016/j.pt.2023.03.006] [PMID: 37031071]
[8]
Legesse Y, Tegegn A, Belachew T, Tushune K. Knowledge, attitude and practice about malaria transmission and its preventive measures among households in urban areas of Assosa Zone, Western Ethiopia. Ethiop J Health Dev 2007; 21(2): 157-65.
[http://dx.doi.org/10.4314/ejhd.v21i2.10044]
[9]
Siddiqui AJ, Bhardwaj J, Saxena J, et al. A critical review on human malaria and schistosomiasis vaccines: Current state, recent advancements, and developments. Vaccines 2023; 11(4): 792.
[http://dx.doi.org/10.3390/vaccines11040792] [PMID: 37112704]
[10]
Fitri LE, Sardjono TW, Winaris N, et al. Bifidobacterium longum administration diminishes parasitemia and inflammation during Plasmodium berghei infection in mice. J Inflamm Res 2023; 16: 1393-404.
[http://dx.doi.org/10.2147/JIR.S400782] [PMID: 37006809]
[11]
Toukam LL, Tatsinkou Fossi B, Taiwe GS, et al. In vivo antimalarial activity of a probiotic bacterium Lactobacillus sakei isolated from traditionally fermented milk in BALB/c mice infected with Plasmodium berghei ANKA. J Ethnopharmacol 2021; 280: 114448.
[http://dx.doi.org/10.1016/j.jep.2021.114448] [PMID: 34303805]
[12]
Mahajan E, Sinha S, Bhatia A, Sehgal R, Medhi B. Evaluation of the effect of probiotic as add-on therapy with conventional therapy and alone in malaria induced mice. BMC Res Notes 2021; 14(1): 246.
[http://dx.doi.org/10.1186/s13104-021-05661-1] [PMID: 34193269]
[13]
Gut AM, Vasiljevic T, Yeager T, Donkor ON. Salmonella infection: Prevention and treatment by antibiotics and probiotic yeasts: a review. Microbiology 2018; 164(11): 1327-44.
[http://dx.doi.org/10.1099/mic.0.000709] [PMID: 30136920]
[14]
Oh B, Kim BS, Kim JW, et al. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter 2016; 21(3): 165-74.
[http://dx.doi.org/10.1111/hel.12270] [PMID: 26395781]
[15]
Xavier-Santos D, Padilha M, Fabiano GA, et al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022; 120: 174-92.
[http://dx.doi.org/10.1016/j.tifs.2021.12.033] [PMID: 35002079]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy